Valuation AstraZeneca PLC Buenos Aires S.E.

Stocks

End-of-day quote Buenos Aires S.E. Other stock markets 2026-07-29			5-day change	1st Jan Change
45.17 ^USD	+0.22%		+2.66%	-9.66%

01:01am	Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials	RE
07-29	ASTRAZENECA : Gets a Buy rating from Bernstein	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	182,034	209,442	209,268	203,171	287,813	270,630	-	-
Change	-	15.06%	-0.08%	-2.91%	41.66%	-5.97%	-	-
Enterprise Value (EV) ¹	206,417	232,365	231,778	227,741	311,187	290,684	283,193	275,352
Change	-	12.57%	-0.25%	-1.74%	36.64%	-6.59%	-2.58%	-2.77%
P/E	1,469x	64.1x	35.4x	29.1x	28.4x	22.3x	19.5x	16.9x
PBR	4.24x	5.65x	5.39x	5.02x	5.96x	5.02x	4.46x	3.79x
PEG	-	0x	0.4x	1.6x	0.6x	1.1x	1.3x	1.1x
Capitalization / Revenue	4.87x	4.72x	4.57x	3.76x	4.9x	4.28x	4.05x	3.8x
EV / Revenue	5.52x	5.24x	5.06x	4.21x	5.3x	4.59x	4.24x	3.86x
EV / EBITDA	27.2x	25.2x	17.1x	13.6x	16x	13x	11.6x	10.3x
EV / EBIT	20.8x	17.4x	15.9x	13.5x	16.8x	13.8x	12.2x	10.8x
EV / FCF	42.4x	26.7x	25.8x	22.9x	26.5x	30.3x	21.9x	19.2x
FCF Yield	2.36%	3.75%	3.88%	4.36%	3.78%	3.3%	4.58%	5.22%
Dividend per Share ²	2.87	2.9	2.9	3.1	3.2	3.325	3.527	3.662
Rate of return	2.44%	2.15%	2.15%	2.37%	1.72%	1.91%	2.02%	2.1%
EPS ²	0.08	2.11	3.81	4.5	6.54	7.815	8.959	10.33
Distribution rate	3,588%	137%	76.1%	68.9%	48.9%	42.5%	39.4%	35.5%
Net sales ¹	37,417	44,351	45,811	54,073	58,739	63,281	66,853	71,311
EBITDA ¹	7,586	9,237	13,580	16,691	19,476	22,338	24,438	26,859
EBIT ¹	9,928	13,350	14,534	16,928	18,478	21,092	23,272	25,589
Net income ¹	112	3,288	5,961	7,035	10,225	12,085	13,710	15,677
Net Debt ¹	24,383	22,923	22,510	24,570	23,374	20,054	12,563	4,722
Reference price ²	117.51	135.16	135.02	131.05	185.60	174.48	174.48	174.48
Nbr of stocks (in thousands)	1,549,159	1,549,528	1,549,926	1,550,317	1,550,726	1,551,024	-	-
Announcement Date	2/10/22	2/9/23	2/8/24	2/6/25	2/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.93x	12.83x	26.95x	0.56%	1,079B
JOHNSON & JOHNSON	28.47x	6.51x	18.01x	2.02%	640B
ABBVIE INC.	33.14x	7.75x	15.92x	2.61%	465B
ROCHE HOLDING AG	20.04x	4.79x	11.87x	2.76%	353B
NOVARTIS AG	22.45x	5.8x	14.46x	2.76%	301B
NOVO NORDISK A/S	14.91x	5.52x	11.38x	3.36%	228B
AMGEN INC.	25.46x	6.65x	11.72x	2.6%	209B
GILEAD SCIENCES, INC.	-47.83x	5.73x	31.65x	2.48%	165B
PFIZER INC.	12.77x	3.12x	7.89x	6.85%	143B
Average	16.15x	6.52x	16.65x	2.89%	398.04B
Weighted average by Cap.	24.81x	8.12x	18.96x	2.13%